Myocardial viability

Nuclear medicine versus stress echocardiography

P. Marzullo, O. Parodi, G. Sambuceti, B. Reisenhofer, A. Gimelli, A. Giorgetti, M. Bartoli, A. L'Abbate

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The failure of nonimaging techniques in the identification of myocardial viability has promoted the clinical application of radioisotopic and echocardiographic methods. Unfortunately, none of these techniques provides, per se, a 100% predictive accuracy and only few studies have been based on the postoperative improvement in regional wall motion, the absolute 'gold standard' for myocardial viability. The recent thallium-201 protocols (reinjection, late redistribution, rest studies) have provided nuclear cardiology with a cell membrane integrity image able to unmask viable myocardium in more than 85% of viable segments. Sestamibi has been introduced as a nonrecirculating flow tracer able to detect transient ischemia as well as thallium-201. Its main limit, a high sensitivity to intermediate reductions in coronary blood flow, determines a high incidence of false positive studies. Positron emission tomography allows the evaluation of regional myocardial blood flow and metabolism. The marker of viable myocardium is the mismatch between reduced blood flow and normal or increased uptake of 18-F fluorodeoxyglucose. This technique allows the detection of viable tissue in most segments showing improved postoperative function. In our experience, applying a multiparametric approach, rest thallium-201 scan, rest sestamibi, dobutamine, and dipyridamole echocardiography showed a sensitivity and a specificity of 86%, 75%, 82%, 75% and 92%, 84%, 92%, and 89%, respectively, in the detection of residual viability. The main advantages of thallium-201 are reproducibility and standardization; those of stress echo are low cost and availability. In patients with severely depressed ventricular function, positron emission tomography retains a primary role when compared to thallium-201 and stress echocardiography.

Original languageEnglish
Pages (from-to)291-302
Number of pages12
JournalEchocardiography
Volume12
Issue number3
Publication statusPublished - 1995

Fingerprint

Stress Echocardiography
Thallium
Nuclear Medicine
Positron-Emission Tomography
Myocardium
Dobutamine
Ventricular Function
Dipyridamole
Fluorodeoxyglucose F18
Regional Blood Flow
Cardiology
Echocardiography
Ischemia
Cell Membrane
Costs and Cost Analysis
Sensitivity and Specificity
Incidence

Keywords

  • positron emission tomography
  • sestamibi scintigraphy
  • stress echocardiography
  • thallium-201 scintigraphy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Marzullo, P., Parodi, O., Sambuceti, G., Reisenhofer, B., Gimelli, A., Giorgetti, A., ... L'Abbate, A. (1995). Myocardial viability: Nuclear medicine versus stress echocardiography. Echocardiography, 12(3), 291-302.

Myocardial viability : Nuclear medicine versus stress echocardiography. / Marzullo, P.; Parodi, O.; Sambuceti, G.; Reisenhofer, B.; Gimelli, A.; Giorgetti, A.; Bartoli, M.; L'Abbate, A.

In: Echocardiography, Vol. 12, No. 3, 1995, p. 291-302.

Research output: Contribution to journalArticle

Marzullo, P, Parodi, O, Sambuceti, G, Reisenhofer, B, Gimelli, A, Giorgetti, A, Bartoli, M & L'Abbate, A 1995, 'Myocardial viability: Nuclear medicine versus stress echocardiography', Echocardiography, vol. 12, no. 3, pp. 291-302.
Marzullo P, Parodi O, Sambuceti G, Reisenhofer B, Gimelli A, Giorgetti A et al. Myocardial viability: Nuclear medicine versus stress echocardiography. Echocardiography. 1995;12(3):291-302.
Marzullo, P. ; Parodi, O. ; Sambuceti, G. ; Reisenhofer, B. ; Gimelli, A. ; Giorgetti, A. ; Bartoli, M. ; L'Abbate, A. / Myocardial viability : Nuclear medicine versus stress echocardiography. In: Echocardiography. 1995 ; Vol. 12, No. 3. pp. 291-302.
@article{1279b7d21b094c659b43c45e9d856a66,
title = "Myocardial viability: Nuclear medicine versus stress echocardiography",
abstract = "The failure of nonimaging techniques in the identification of myocardial viability has promoted the clinical application of radioisotopic and echocardiographic methods. Unfortunately, none of these techniques provides, per se, a 100{\%} predictive accuracy and only few studies have been based on the postoperative improvement in regional wall motion, the absolute 'gold standard' for myocardial viability. The recent thallium-201 protocols (reinjection, late redistribution, rest studies) have provided nuclear cardiology with a cell membrane integrity image able to unmask viable myocardium in more than 85{\%} of viable segments. Sestamibi has been introduced as a nonrecirculating flow tracer able to detect transient ischemia as well as thallium-201. Its main limit, a high sensitivity to intermediate reductions in coronary blood flow, determines a high incidence of false positive studies. Positron emission tomography allows the evaluation of regional myocardial blood flow and metabolism. The marker of viable myocardium is the mismatch between reduced blood flow and normal or increased uptake of 18-F fluorodeoxyglucose. This technique allows the detection of viable tissue in most segments showing improved postoperative function. In our experience, applying a multiparametric approach, rest thallium-201 scan, rest sestamibi, dobutamine, and dipyridamole echocardiography showed a sensitivity and a specificity of 86{\%}, 75{\%}, 82{\%}, 75{\%} and 92{\%}, 84{\%}, 92{\%}, and 89{\%}, respectively, in the detection of residual viability. The main advantages of thallium-201 are reproducibility and standardization; those of stress echo are low cost and availability. In patients with severely depressed ventricular function, positron emission tomography retains a primary role when compared to thallium-201 and stress echocardiography.",
keywords = "positron emission tomography, sestamibi scintigraphy, stress echocardiography, thallium-201 scintigraphy",
author = "P. Marzullo and O. Parodi and G. Sambuceti and B. Reisenhofer and A. Gimelli and A. Giorgetti and M. Bartoli and A. L'Abbate",
year = "1995",
language = "English",
volume = "12",
pages = "291--302",
journal = "Echocardiography",
issn = "0742-2822",
publisher = "Blackwell Publishing Inc.",
number = "3",

}

TY - JOUR

T1 - Myocardial viability

T2 - Nuclear medicine versus stress echocardiography

AU - Marzullo, P.

AU - Parodi, O.

AU - Sambuceti, G.

AU - Reisenhofer, B.

AU - Gimelli, A.

AU - Giorgetti, A.

AU - Bartoli, M.

AU - L'Abbate, A.

PY - 1995

Y1 - 1995

N2 - The failure of nonimaging techniques in the identification of myocardial viability has promoted the clinical application of radioisotopic and echocardiographic methods. Unfortunately, none of these techniques provides, per se, a 100% predictive accuracy and only few studies have been based on the postoperative improvement in regional wall motion, the absolute 'gold standard' for myocardial viability. The recent thallium-201 protocols (reinjection, late redistribution, rest studies) have provided nuclear cardiology with a cell membrane integrity image able to unmask viable myocardium in more than 85% of viable segments. Sestamibi has been introduced as a nonrecirculating flow tracer able to detect transient ischemia as well as thallium-201. Its main limit, a high sensitivity to intermediate reductions in coronary blood flow, determines a high incidence of false positive studies. Positron emission tomography allows the evaluation of regional myocardial blood flow and metabolism. The marker of viable myocardium is the mismatch between reduced blood flow and normal or increased uptake of 18-F fluorodeoxyglucose. This technique allows the detection of viable tissue in most segments showing improved postoperative function. In our experience, applying a multiparametric approach, rest thallium-201 scan, rest sestamibi, dobutamine, and dipyridamole echocardiography showed a sensitivity and a specificity of 86%, 75%, 82%, 75% and 92%, 84%, 92%, and 89%, respectively, in the detection of residual viability. The main advantages of thallium-201 are reproducibility and standardization; those of stress echo are low cost and availability. In patients with severely depressed ventricular function, positron emission tomography retains a primary role when compared to thallium-201 and stress echocardiography.

AB - The failure of nonimaging techniques in the identification of myocardial viability has promoted the clinical application of radioisotopic and echocardiographic methods. Unfortunately, none of these techniques provides, per se, a 100% predictive accuracy and only few studies have been based on the postoperative improvement in regional wall motion, the absolute 'gold standard' for myocardial viability. The recent thallium-201 protocols (reinjection, late redistribution, rest studies) have provided nuclear cardiology with a cell membrane integrity image able to unmask viable myocardium in more than 85% of viable segments. Sestamibi has been introduced as a nonrecirculating flow tracer able to detect transient ischemia as well as thallium-201. Its main limit, a high sensitivity to intermediate reductions in coronary blood flow, determines a high incidence of false positive studies. Positron emission tomography allows the evaluation of regional myocardial blood flow and metabolism. The marker of viable myocardium is the mismatch between reduced blood flow and normal or increased uptake of 18-F fluorodeoxyglucose. This technique allows the detection of viable tissue in most segments showing improved postoperative function. In our experience, applying a multiparametric approach, rest thallium-201 scan, rest sestamibi, dobutamine, and dipyridamole echocardiography showed a sensitivity and a specificity of 86%, 75%, 82%, 75% and 92%, 84%, 92%, and 89%, respectively, in the detection of residual viability. The main advantages of thallium-201 are reproducibility and standardization; those of stress echo are low cost and availability. In patients with severely depressed ventricular function, positron emission tomography retains a primary role when compared to thallium-201 and stress echocardiography.

KW - positron emission tomography

KW - sestamibi scintigraphy

KW - stress echocardiography

KW - thallium-201 scintigraphy

UR - http://www.scopus.com/inward/record.url?scp=0028933119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028933119&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 291

EP - 302

JO - Echocardiography

JF - Echocardiography

SN - 0742-2822

IS - 3

ER -